Gadodiamide is a gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. GBCAs constitute the largest group of MR agents, and they are thought to be safer than nonionic iodinated contrast agents.
- Mechanism
- Curator reviewed · 1 reference
Gadodiamide paramagnetic molecule that develops a magnetic moment when placed in a magnetic field. The magnetic moment alters the relaxation rates of water protons in its vicinity in the body. Its use in magnetic resonance imaging (MRI) allows to selectively increase contrast in tissues where gadodiamide accumulates.
- Primary indication
- Gadodiamide is indicated for the visualization of lesions with abnormal vascularity in the brain (intracranial lesions), spine, and associated tissues and the body (including the thoracic (noncardiac), abdominal, pelvic cavities, and retroperitoneal space) by the...Curator reviewed · 5 structured indications
- Formula / weight
- C16H26GdN5O8 · 573.66 g/mol (avg)
- First approval
- Canada, 2006 · United States, 2002
- Code names
- S-041
- Brand names
Resolves to
HZHFFEYYPYZMNU-UHFFFAOYSA-KSMILES[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=OWhat you can answer from here — as of September 12, 2026
Which drugs share a target with Gadodiamide, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account